Join this free webinar, hosted by DDW, to learn how Evotec is planning to shorten timelines for small molecule drug discovery projects.  

The webinar will take place on 10 November, 8am PST / 11am EST / 4PM GMT / 5PM CET.

Using its ‘Every Compound a Candidate (ECC)’ approach, Evotec is aiming to reduce timelines to under two years. This webinar will explore the current challenges facing small molecule drug discovery and how Evotec’s approach, which combines operational excellence with calculated risk-taking in decision-making, can accelerate drug discovery while improving quality.

You will hear from:

  • Ashley Jarvis, EVP, Head of Global Chemistry
  • Dermot McGinnity, EVP, Head of Global Discovery DMPK
  • Christophe Boldron, VP, Head of Molecular Architects Toulouse
  • Jerome Meneyrol, VP Discovery Chemistry, Molecular Architect

Register now.